Piper betle

Few plants sit deeper in Malay material culture than sireh. Zamri and
colleagues' 2023 scoping review traces the leaf through Malay medical
manuscripts — recorded for conditions associated with infection, menstrual
complaints and postpartum care — and bridges the manuscript record to the
modern laboratory literature [1]. The leaf's ceremonial and social life,
from kunyah sireh onward, is documented alongside its household uses as a
wash and compress [2]. One disambiguation matters and this monograph makes
it early: sireh the leaf is not the betel quid. The quid — areca nut and
lime, wrapped in the leaf — is a different preparation with its own grave
safety literature, addressed under Safety below.

The leaf's most studied constituent is hydroxychavicol, alongside
chavibetol, eugenol, chavicol and allylpyrocatechol [2]. Hydroxychavicol
carries most of the laboratory record: Sharma and colleagues (2009)
reported minimum inhibitory concentrations of 62.5–500 µg/ml against oral
organisms, activity against Streptococcus mutans biofilm, and a
post-exposure suppression effect of six to seven hours [3]. Singh and
colleagues (2018) traced a mechanism — reactive-oxygen-mediated DNA damage
and division arrest in Escherichia coli [4].

The in vitro record is broad. Beyond the work above, Ali and colleagues
(2010) screened hydroxychavicol against 124 fungal strains and reported
minimum inhibitory concentrations of 7.81–62.5 µg/ml against dermatophytes
and 15.62–500 µg/ml against yeasts, with activity against Candida
biofilm [5]; a Malaysian group reported combination effects of
hydroxychavicol with amphotericin B against oral Candida species [6].

Human evidence is one small trial in a different setting: Sundaram and
colleagues (2021) randomised 60 periodontitis patients to a piper-extract
mouthwash or chlorhexidine after debridement and reported comparable
reduction of Porphyromonas gingivalis [7]. It is small, single-site, and
an oral rinse — not the skin and hygiene uses of the Malay record. The
laboratory case is genuinely strong for a grade C; the clinical case has
barely begun.

A second human trial has since been published in the same domain: a
randomised crossover study in sixty participants with mild gingivitis
found a betel-leaf dentifrice reduced gingival bleeding more than the
comparator over twenty days [9]. A 2021 review gathers the antimicrobial
literature — bacterial and fungal — together with a safety-profile section for the
leaf specifically [10], and Malaysian work has examined the leaf extract
in other models entirely [11].

Two small oral-care trials move the ladder to the clinical rung. They do
not touch the skin and hygiene uses the Malay record actually describes,
which is why the grade stays at C.

The essential distinction: the International Agency for Research on Cancer
classifies betel quid — with or without tobacco — and areca nut as Group 1
carcinogens [8]. That evaluation attaches to the quid preparation with
Areca catechu, not to Piper betle leaf alone, which was not the
evaluated agent; the honest statement is "not the evaluated agent," never
"shown safe." Eugenol, present in the leaf, is a recognised contact
allergen, and the long-term mucosal safety of repeated topical leaf
exposure is uncharacterised. Patch-test before use; discontinue on
irritation.